Research ArticleArticle

Interrelationships between Infliximab and Recombinant Tumor Necrosis Factor-α in Plasma Using Minimal Physiologically Based Pharmacokinetic Models

Xi Chen, Debra C. DuBois, Richard R. Almon and William J. Jusko
Drug Metabolism and Disposition July 2017, 45 (7) 790-797; DOI: https://doi.org/10.1124/dmd.116.074807
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Pharmacokinetic Interactions of TNF-α and Infliximab

Xi Chen, Debra C. DuBois, Richard R. Almon and William J. Jusko
Drug Metabolism and Disposition July 1, 2017, 45 (7) 790-797; DOI: https://doi.org/10.1124/dmd.116.074807
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section